Stocks · Healthcare · Biotechnology
iBio, Inc. IBIO
$1.13 +1.80% Close, Oct 2, 2026 · NASDAQ · Market cap $72.3M
Expensive vs sector
Next earnings report: Nov 11, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $100,000, down 75.0% from a year earlier, slowing from -20.0% a quarter earlier.
- Operating margin narrowed to -35141.0% from -4650.5% a year earlier.
- The diluted share count rose 533.6% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 7%
- Revenue growth accelerationBottom 6%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 33%
- Gross marginTop 2%
- Operating marginBottom 2%
- Accruals (lower is better)Top 35%
- Interest coverBottom 7%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 25%
- Free-cash-flow yieldBottom 14%
- EBITDA / enterprise valueBottom 2%
- Sales / enterprise valueBottom 6%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 30%
- 6-month returnBottom 7%
- 1-year return vs S&P 500Top 32%
- Distance from 52-week highBottom 8%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 28%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyBottom 47%
- Upside to consensus price targetTop 9%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 30%
- Maximum drawdown, 3 yearsBottom 11%
- Beta vs S&P 500 (lower is better)Top 49%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -20.0% | -75.0% | ↓ |
| Gross margin | 100.0% | 100.0% | → |
| Operating margin | -4650.5% | -35141.0% | ↓ |
| FCF margin | -3830.0% | -23796.0% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -75.0% | -20.0% | ↓ | Bottom 7% |
| Gross margin | 100.0% | 100.0% | → | Top 2% |
| Operating margin | -35141.0% | -4650.5% | ↓ | Bottom 2% |
| Net margin | -33044.0% | -4594.3% | ↓ | — |
| Free-cash-flow margin | -23796.0% | -3830.0% | ↓ | — |
| Return on invested capital | -40.0% | — | Bottom 33% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -9.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1373.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +1026.4 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -663.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -159.09%
- Shareholder yield
- -159.09%
- Share count change, 1 year
- +533.6%
- Share count change, 3-year CAGR
- +368.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 28, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -11.0%
- Average 2-day reaction, last 8
- -2.3%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $5.00
- Target vs current price
- +342.5%
- Analysts with a rating
- 4
- Share rating Buy or Strong Buy
- 75%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 28, 2026 | +42.3% | -2.9% | -7.1% | -15.0% | — |
| May 12, 2026 | -16.7% | -3.0% | -14.5% | +2.4% | -16.3% |
| Feb 10, 2026 | -12.5% | -5.8% | -5.0% | -1.2% | -26.6% |
| Nov 12, 2025 | -57.1% | +0.8% | -2.4% | +126.6% | +94.4% |
| Sep 5, 2025 | +20.5% | +2.9% | +18.7% | +2.8% | +51.6% |
| May 2, 2025 | -25.6% | -1.9% | -19.4% | -25.2% | -33.0% |
| Feb 10, 2025 | -6.7% | -8.1% | -7.8% | +48.9% | -77.2% |
| Nov 12, 2024 | +4.2% | -0.4% | -14.8% | +3.9% | +33.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 28, 2026 | -$0.04 | -$0.07 | +42.3% | — |
| May 12, 2026 | -$0.07 | -$0.06 | -16.7% | — |
| Feb 10, 2026 | -$0.09 | -$0.08 | -12.5% | — |
| Nov 12, 2025 | -$0.11 | -$0.07 | -57.1% | $100,000 |
| Sep 5, 2025 | -$0.31 | -$0.39 | +20.5% | $200,000 |
| May 2, 2025 | -$0.49 | -$0.39 | -25.6% | — |
| Feb 10, 2025 | -$0.48 | -$0.45 | -6.7% | $200,000 |
| Nov 12, 2024 | -$0.46 | -$0.48 | +4.2% | — |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 181.49× | — | — | Bottom 6% |
| Free-cash-flow yield | -32.89% | — | — | Bottom 14% |
| Earnings yield | -28.79% | — | — | Bottom 25% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -8.4%
- 200-day average slope (20 days)
- -1.2%
- Distance from 50-day average
- -15.1%
- Distance from 200-day average
- -37.9%
- RSI (14)
- 35.5
- Relative volume
- 1.04×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 45.3%
- Volatility vs own 5-year history
- 2th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.10
- Correlation with S&P 500
- 0.14
- Current drawdown from 1-year high
- -63.2%
- Maximum drawdown, 3 years
- -92.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 9, 2021 | Aug 12, 2025 | -100.0% | 1131 days | Not yet recovered |
| Oct 13, 2020 | Dec 31, 2020 | -53.1% | 55 days | 23 days (Feb 4, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $72.3M
- EPS, diluted (TTM)
- -$0.33
- Revenue (TTM)
- $100,000
- 52-week range
- $0.78 – $3.82
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Revenue | $1.9M | $0 | $225,000 | $400,000 | $100,000 |
| Gross profit | -$1.9M | $0 | $225,000 | $400,000 | $100,000 |
| Operating income | -$29.7M | -$29.3M | -$16.6M | -$18.6M | -$35.1M |
| Net income | -$50.4M | -$65.0M | -$24.9M | -$18.4M | -$33.0M |
| EPS (diluted) | -$2,889.06 | -$106.18 | -$6.50 | -$1.75 | -$0.32 |
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | Q4 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $200,000 | $0 | $200,000 | $100,000 | $0 | $0 | $0 |
| Net income | -$4.0M | -$4.4M | -$4.9M | -$5.2M | -$5.7M | -$9.0M | -$7.7M | -$10.6M |
| EPS (diluted) | -$0.46 | -$0.48 | -$0.49 | -$0.31 | -$0.11 | -$0.09 | -$0.06 | -$0.06 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Operating cash flow | -$37.8M | -$30.4M | -$18.6M | -$15.3M | -$23.2M |
| Capital expenditure | -$7.3M | -$5.7M | -$210,000 | -$16,000 | -$578,000 |
| Free cash flow | -$45.1M | -$36.2M | -$18.8M | -$15.3M | -$23.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $77,000 | $11.4M | $25.5M | $9.7M | $109.6M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $88.0M
- Total assets
- $99.1M
- Total liabilities
- $13.4M
- Total debt
- $2.2M
- Net debt
- -$54.2M
- Shareholders’ equity
- $85.7M
As of Jun 30, 2026 (filed Aug 28, 2026).
Short interest
- Shares sold short
- 4,936,917
- Days to cover
- 9.99
- Change vs previous report
- -5.1%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Nov 29, 2023
- 1-for-20
- Oct 10, 2022
- 1-for-25
- Jun 11, 2018
- 1-for-10